We are live on
!
Find out more
ACM
Ativo Capital Management Portfolio holdings
AUM
$115M
1-Year Est. Return
19.02%
This Fund
S&P 500
This Quarter
Est. Return
+2.97%
1 Year Est. Return
+19.02%
3 Year Est. Return
+57.9%
5 Year Est. Return
+80.23%
10 Year Est. Return
+380.01%
AUM
$284M
AUM Growth
+$28.5M
(+11%)
Cap. Flow
+$27.6M
Cap. Flow
% of AUM
9.72%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
259
New
69
Increased
62
Reduced
94
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$5.44M |
| 2 |
RENX
RELX N.V.
RENX
|
+$3.17M |
| 3 |
Aptiv
APTV
|
+$2.95M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$2.51M |
| 5 |
Everest Group
EG
|
+$2.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$5.11M |
| 2 |
TTM
Tata Motors Limited
TTM
|
+$2.35M |
| 3 |
Xenon Pharmaceuticals
XENE
|
+$2.32M |
| 4 |
Open Text
OTEX
|
+$1.93M |
| 5 |
SHPG
Shire pic
SHPG
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.94% |
| 2 | Healthcare | 19.81% |
| 3 | Financials | 10.98% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Industrials | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$35.9B
| $11.7M | 4.12% |
165,941
-18,602
| -10% | -$1.15M |
|
|
2
Accenture
ACN
$89.9B
| $10.7M | 3.78% |
104,064
+56,919
| +121% | +$5.44M |
|
3
Sensata Technologies
ST
$6.65B
| $10.4M | 3.67% |
204,094
-6,526
| -3% | -$365K |
|
|
WBC
4
DELISTED
WABCO HOLDINGS INC.
WBC
| $8.4M | 2.96% |
68,345
+19,896
| +41% | +$2.51M |
|
|
5
Aptiv
APTV
$12B
| $7.61M | 2.68% |
98,290
+34,488
| +54% | +$2.95M |
|
|
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.5M | 2.64% |
54,134
-1,739
| -3% | -$248K |
|
|
CBPO
7
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $7.26M | 2.56% |
59,101
-688
| -1% | -$72.3K |
|
8
TE Connectivity
TEL
$58.8B
| $7.1M | 2.5% |
115,159
-2,896
| -2% | -$200K |
|
9
SAP
SAP
$187B
| $5.46M | 1.92% |
75,501
-25,738
| -25% | -$1.91M |
|
10
LyondellBasell Industries
LYB
$19.5B
| $4.66M | 1.64% |
51,687
+11,024
| +27% | +$1.11M |
|
11
TSMC
TSM
$2.09T
| $4.34M | 1.53% |
203,871
+81,325
| +66% | +$1.94M |
|
12
Amdocs
DOX
$5.53B
| $4.19M | 1.48% |
72,096
-1,673
| -2% | -$92K |
|
13
Brookfield
BN
$102B
| $3.91M | 1.38% |
319,957
-10,074
| -3% | -$128K |
|
14
AB InBev
BUD
$158B
| $3.81M | 1.34% |
31,220
+11,269
| +56% | +$1.38M |
|
15
CGI
GIB
$13.9B
| $3.66M | 1.29% |
95,941
-1,777
| -2% | -$76.6K |
|
16
Dr. Reddy's Laboratories
RDY
$9.82B
| $3.46M | 1.22% |
260,335
+79,740
| +44% | +$880K |
|
17
Lesaka Technologies
LSAK
$388M
| $3.17M | 1.12% |
158,148
+109,630
| +226% | +$1.65M |
|
18
AerCap
AER
$23.9B
| $2.78M | 0.98% |
60,101
-2,235
| -4% | -$106K |
|
19
Toyota
TM
$210B
| $2.51M | 0.88% |
19,493
+1,319
| +7% | +$182K |
|
20
UnitedHealth
UNH
$382B
| $2.41M | 0.85% |
19,776
-1,122
| -5% | -$133K |
|
21
Mastercard
MA
$477B
| $2.38M | 0.84% |
24,545
+576
| +2% | +$52.9K |
|
22
Synopsys
SNPS
$71.5B
| $2.38M | 0.84% |
46,577
+38,722
| +493% | +$1.89M |
|
23
Danaher
DHR
$135B
| $2.37M | 0.83% |
38,428
+860
| +2% | +$49.3K |
|
24
Simon Property Group
SPG
$74.5B
| $2.3M | 0.81% |
12,088
-881
| -7% | -$162K |
|
25
Equifax
EFX
$20.3B
| $2.27M | 0.8% |
+22,135
| New | +$2.16M |
|
Similar funds
IASG
PCM
CF
B
ACM
PHWM
RA
MCI
Ativo Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Ativo Capital Management held 259 positions worth $284M, up 11% from $255M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ativo Capital Management deployed $27.6M of net new capital in Q2 2015, opening 69 new positions and adding to 62 existing holdings. Its largest new stake was Everest Group: 12,139 shares worth $2.23M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SAP, an estimated $1.91M trimmed.
- Ativo Capital Management's largest Q2 2015 buy was Everest Group: 12,139 shares worth $2.23M.
- Ativo Capital Management added most to Accenture in Q2 2015, an estimated $5.44M increase.
- Ativo Capital Management's biggest Q2 2015 reduction was SAP, cutting an estimated $1.91M.
- Ativo Capital Management fully exited Pentair in Q2 2015, selling an estimated $5.11M.
- Ativo Capital Management's ten largest holdings make up 28% of its $284M portfolio in Q2 2015.
- Ativo Capital Management opened 69 new positions and closed 34 in Q2 2015.
- Ativo Capital Management's portfolio value rose 11% quarter-over-quarter to $284M.
Based on Ativo Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.